CeQur SA Completes USD 100 Million Series E Financing Round

Walder Wyss AG has advised CeQur SA. CeQur SA, a Swiss medical device company specializing in insulin-delivery solutions for people with diabetes, has completed a USD…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Marco Zingaro

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here